WallStSmart
IART

Integra LifeSciences Holdings

NASDAQ: IART · HEALTHCARE · MEDICAL DEVICES

$10.54
+4.56% today

Updated 2026-04-30

Market cap
$785.61M
P/E ratio
P/S ratio
0.48x
EPS (TTM)
$-6.74
Dividend yield
52W range
$9 – $17
Volume
0.8M

Integra LifeSciences Holdings (IART) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$71.70M$47.03M$72.59M$143.24M$105.57M$104.33M$58.72M$53.27M$79.46M$94.48M$116.41M$114.54M$199.68M$231.43M$203.83M$312.43M$264.47M$139.96M$129.38M$50.38M
Capital expenditures$11.52M$22.57M$13.40M$27.57M$37.14M$38.42M$69.03M$47.85M$42.40M$33.41M$47.33M$43.50M$77.74M$134.53M$63.89M$48.08M$47.09M$66.86M$104.42M$81.44M
Depreciation
Stock-based comp$-1.33M$-1.22M$-1.22M$15.58M$17.21M$26.80M$9.05M$10.39M$15.11M$15.45M$17.31M$21.55M$20.78M$21.25M$19.59M$36.21M$27.73M$20.14M$24.38M$18.58M
Free cash flow$60.18M$24.45M$59.19M$115.67M$68.43M$65.90M$-10.32M$5.42M$37.07M$61.07M$69.08M$71.04M$121.94M$96.90M$139.94M$264.35M$217.38M$73.09M$24.96M$-31.05M
Investing cash flow
Financing cash flow
Dividends paid$348.40M$422.02M$0.00$378.70M$0.00$0.00$0.00$0.00$0.00$0.00$434000.00$44.56M$2.02M$5.46M$93.24M
Share repurchases
Debt repayment
Net change in cash$56.87M$-27.95M$-3.87M$23.68M$-48.62M$-23.86M$53.92M$72.88M$-36.10M$60.00M$257.38M$52.76M$-46.06M